EUVIMED · CrossrefJournal
International Journal of Technology Assessment in Health Care
ISSN 0266-4623 · Cambridge University Press (CUP)
Latest articles
A comparative analysis in medicines coverage decisions in four European countries
Testing Deliberation in HTA: Four Tests of Decision Quality
BEYOND RECOMMENDATIONS: A SYSTEMATIC REVIEW OF VALUES, OUTCOMES AND IMPACT OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES WORLDWIDE
Integrating equity considerations into health technology assessment in Latin America: practical guidance from the 2025 HTAi Policy Forum
DIRECTVALU: ASSESSING INDIRECTNESS OF INDIVIDUAL STUDIES THAT MEASURE PEOPLES’ VALUES, UTILITIES, OR THE IMPORTANCE OF OUTCOMES
Organizational impact in healthcare in France: a decade of insights but chicken and egg situation
Establishing a Consumer Panel to Inform Health Technology Assessment Processes and Policy: impact and insights from Singapore’s experience
A systematic literature review (SLR) on the adoption of artificial intelligence-assisted SLRS: implications for health technology assessments
Patient involvement in health technology assessment: a new process in Singapore
Early technology review during prototype development and at proof of concept: the case for developing a sequential versus a single-stage approach to early evidence development for health technologies
Health technology assessment in Eastern Europe and Central Asia: an updated SWOT analysis
The role of financial distress as a patient-relevant endpoint in early benefit assessments for oncology drugs: a mixed-methods document analysis
Trust, validation, and accountability: implementing uses of generative artificial intelligence into Health Technology Assessment practice
Two decades of impact: lessons from the HTAi Patient and Citizen Involvement in HTA Interest Group
Advancing health technology assessment in the Middle East and North Africa: insights and outcomes from the 2025 HTAi regional meeting
Cost-utility of screening with liquid cytology or p16/Ki67 dual stain in women identified in cervical cancer triage with non 16/18 HR-HPV
Considering research waste in economic evaluations of low-dose computed tomography screening for lung cancer
What the future holds: the growing role of real-world evidence in health technology assessment in Malaysia
Unveiling trends: insights into medicines reimbursement recommendations and health technology management in Ireland (2018–2023)
How users perceive meta-analysis of economic evaluations
Ontology-driven generation of parameters for health technology assessment models: a prompt engineering study
Advancing health technology assessment in Taiwan: over 15 years of evidence-based reform, innovation, and patient partnership
Beyond efficiency: reimagining health technology assessment in the age of artificial intelligence
From HTA to the bedside: aligning GenAI validation with clinical reality
Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment – a qualitative analysis
Competencies for health technology assessment professionals: a scoping review and content analysis
Practice and challenges of HB-HTA in China: insights from hospital management and clinical perspectives
What is new in the early health technology assessment’s new definition?
Incorporating climate impact in health care decisions: new criteria to be tested in the Netherlands
Policy dialogue on health technology assessment in Middle East and North Africa: reporting from an HTAi initiative
Volumes
2026 · 1092025 · 3512024 · 4782023 · 2842022 · 3482021 · 1862020 · 2112019 · 3462018 · 3742017 · 4382016 · 652015 · 762014 · 992013 · 762012 · 772011 · 742010 · 862009 · 1482008 · 742007 · 702006 · 732005 · 852004 · 812003 · 722002 · 322001 · 612000 · 1001999 · 751998 · 981997 · 721996 · 701995 · 981994 · 1011993 · 861992 · 1331991 · 1421990 · 831989 · 861988 · 871987 · 97
EUVIMED